企業プロフィール
Xencor 株価・ニュース・カタリスト
- ティッカー:
- XNCR
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
29.00 USD (+4.30%)
終値
最終更新: 2026年8月24日
831M USD
時価総額
株価変動の要因
As of Aug 24, 2026, XNCR closed up 4.30% at $29.00. No new same-company headline was identified in the current news window.
企業概要
事業概要
Xencor is a biotechnology company built around antibody engineering and next-generation immunology and oncology programs. Its platform approach gives it optionality across multiple therapeutic areas.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Xencor sits in specialty biotechnology.
ビジネスモデルの特徴
The business blends partnered programs, internal development, and platform science, with valuation tied to data quality and collaboration economics.
バイオ業界での位置付け
Xencor is a platform antibody name that can re-rate quickly when clinical data or partner progress strengthens confidence in the platform.
今後のカタリスト
- Xencor's catalysts are XmAb platform updates, including vudalimab and other bispecific programs that can still create partnered or internal value. The company needs data that show the platform keeps producing.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。